The French pharmaceutical company, Servier, announced yesterday that it had received a positive opinion from the European Medicines Agency (EMA) regarding its drug, “Lonserve”, which is taken with an antibody to fight colorectal cancer, which is…
A promising drug against colon cancer is receiving positive reviews
